P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA

Bibliographic Details
Main Authors: I. Ntanasis-Stathopoulos, M. Gavriatopoulou, E. Eleutherakis-Papaiakovou, P. Malandrakis, V. Spiliopoulou, R.E. Syrigou, F. Theodorakakou, D. Fotiou, M. Migkou, M. Roussou, E. Kastritis, M.A. Dimopoulos, E. Terpos
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3
_version_ 1827332261111922688
author I. Ntanasis-Stathopoulos
M. Gavriatopoulou
E. Eleutherakis-Papaiakovou
P. Malandrakis
V. Spiliopoulou
R.E. Syrigou
F. Theodorakakou
D. Fotiou
M. Migkou
M. Roussou
E. Kastritis
M.A. Dimopoulos
E. Terpos
author_facet I. Ntanasis-Stathopoulos
M. Gavriatopoulou
E. Eleutherakis-Papaiakovou
P. Malandrakis
V. Spiliopoulou
R.E. Syrigou
F. Theodorakakou
D. Fotiou
M. Migkou
M. Roussou
E. Kastritis
M.A. Dimopoulos
E. Terpos
author_sort I. Ntanasis-Stathopoulos
collection DOAJ
first_indexed 2024-03-07T16:56:27Z
format Article
id doaj.art-d4a76e86e2a140cb8b89c09d5eb94cef
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:56:27Z
publishDate 2023-05-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-d4a76e86e2a140cb8b89c09d5eb94cef2024-03-03T03:59:02ZengWileyHemaSphere2572-92412023-05-017S2424210.1097/01.HS9.0000936356.81008.a3202305002-00076P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMAI. Ntanasis-Stathopoulos0M. Gavriatopoulou1E. Eleutherakis-Papaiakovou2P. Malandrakis3V. Spiliopoulou4R.E. Syrigou5F. Theodorakakou6D. Fotiou7M. Migkou8M. Roussou9E. Kastritis10M.A. Dimopoulos11E. Terpos12Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greecehttp://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3
spellingShingle I. Ntanasis-Stathopoulos
M. Gavriatopoulou
E. Eleutherakis-Papaiakovou
P. Malandrakis
V. Spiliopoulou
R.E. Syrigou
F. Theodorakakou
D. Fotiou
M. Migkou
M. Roussou
E. Kastritis
M.A. Dimopoulos
E. Terpos
P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
HemaSphere
title P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
title_full P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
title_fullStr P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
title_full_unstemmed P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
title_short P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
title_sort p57 pre exposure prophylaxis for covid 19 with tixagevimab cilgavimab evusheld in patients with multiple myeloma
url http://journals.lww.com/10.1097/01.HS9.0000936356.81008.a3
work_keys_str_mv AT intanasisstathopoulos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT mgavriatopoulou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT eeleutherakispapaiakovou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT pmalandrakis p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT vspiliopoulou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT resyrigou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT ftheodorakakou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT dfotiou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT mmigkou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT mroussou p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT ekastritis p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT madimopoulos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma
AT eterpos p57preexposureprophylaxisforcovid19withtixagevimabcilgavimabevusheldinpatientswithmultiplemyeloma